In Vivo Selection of Genetically Modified Erythroid Cells Using a Jak2-Based Cell Growth Switch
Authors:
- Michael A. WeinreichMWMichael A. Weinreich
- Kenji IharaKIKenji Ihara
- Robert E. RichardRRRobert E. Richard
- C.Anthony BlauCBC.Anthony Blau
Open Access
- 30 September 2004
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 10 (3) , 456-468
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Small-Molecule-Directed Mpl Signaling Can Complement Growth Factors to Selectively Expand Genetically Modified Cord Blood CellsStem Cells, 2003
- Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cellsBlood, 2001
- Pharmacologically regulated cell therapyBlood, 2001
- In vivo selection using a cell-growth switchNature Genetics, 2000
- Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerizationBlood, 2000
- A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cellsThe Journal of Gene Medicine, 1999
- Targeted expansion of genetically modified bone marrow cellsProceedings of the National Academy of Sciences, 1998
- Stimulating Cell Proliferation Through the Pharmacologic Activation of c-kitBlood, 1998
- A proliferation switch for genetically modified cellsProceedings of the National Academy of Sciences, 1997
- Controlling Signal Transduction with Synthetic LigandsScience, 1993